Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

48 MEDICAL GROUP RAF LAKENHEATH

UEI: R61MLL4SXZK6

48 MEDICAL GROUP RAF LAKENHEATH is a federal contractor, registered under UEI R61MLL4SXZK6. It has been awarded $76,800 across 1 federal contract. Primary work spans Medical Laboratories. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

R61MLL4SXZK6

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Defense$76.8K100%

Awards by NAICS

621511 - Medical Laboratories$76.8K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in 48 MEDICAL GROUP RAF LAKENHEATH's top NAICS codes and agencies

Medical Laboratory Testing – MRD Analysis via clonoSEQ AssayThe contract calls for the performance of 100 annual Measurable Residual Disease tests using the proprietary clonoSEQ assay for Veterans diagnosed with hematologic malignancies. Each test must be conducted using an FDA-cleared and CLIA-validated methodology to ensure clinical accuracy and regulatory compliance. The work is structured as a subcontract under the Department of Veterans Affairs, specifically managed by the 244-NETWORK Contract Office 4, and falls under the NAICS code 621511 for medical laboratory services. The solicitation was posted on July 31, 2026, with a response deadline of August 10, 2026, indicating a tight procurement timeline. While the place of performance and point of contact details are not specified, the requirement emphasizes standardized, validated laboratory testing to support clinical decision-making for Veterans, with no set-aside provisions identified.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Q301--Lab Testing Services - clonoSEQ Measurable Residual Disease Test Pittsburgh VA Medical Center - Pittsburgh, PA

Solicitation # 36C24426Q0855

The Department of Veterans Affairs’ Network Contracting Office 4 intends to award a sole source contract to Adaptive Biotechnologies Corporation for the provision of clonoSEQ Measurable Residual Disease (MRD) testing services at the Pittsburgh VA Medical Center. This action is justified under FAR 6.103-1 because Adaptive Biotechnologies is the exclusive provider of the clonoSEQ assay, a proprietary, FDA-cleared, and CLIA-validated molecular test used to detect MRD in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other lymphoid malignancies. The contract will use simplified acquisition procedures, be firm fixed price, and span a five-year period with an annual quantity of 100 tests. The solicitation number is 36C24426Q0855, and the NAICS code is 621511 with a size standard of $41.5 million. Any interested party may submit a capability statement prior to the response deadline of August 10, 2026, at 8:00 AM Eastern Standard Time, but the Government retains full discretion to proceed without competition based on the unique nature of the technology and the absence of viable alternatives. Responses must include the company name, SAM UEI number, address, point of contact details, business size, and evidence demonstrating the ability to perform the service, including relevant experience, contract numbers, dollar amounts, performance periods, and customer contacts. All submissions must be emailed to Mickeya Linzie at mickeya.linzie@va.gov and must clearly state whether the respondent is the direct provider or an authorized reseller. No submissions will be accepted after the deadline, and all information provided becomes the property of the Government.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Drug and Alcohol Testing ServicesThe contract requires the provision of drug and alcohol testing services for construction personnel in alignment with SAMHSA guidelines, ensuring compliance with federal standards for workplace safety. Testing must include EMIT screening as an initial method followed by definitive GC/MS confirmation to ensure accurate and legally defensible results. The scope of work is specifically targeted at personnel involved in construction activities under the purview of the Professional Services Department of the Los Angeles Community College District, with all testing protocols required to meet the highest regulatory benchmarks for accuracy, chain of custody, and reporting. The solicitation is classified as a subcontract with a response deadline of September 1, 2026, and is associated with NAICS code 621511, indicating clinical laboratory services. The place of performance and agency location are not precisely defined in the data, but the contracting entity operates within California. There is no set-aside designation specified, meaning the contract is open to all eligible vendors. The official posting is accessible via the provided vendor portal link, and prospective bidders must ensure full adherence to SAMHSA compliance requirements, laboratory accreditation standards, and timely submission of proposed services and pricing by the stated deadline.

Professional Services Department of Los Angeles Community College District

POSTED

DEADLINE

in about 1 month

Newborn Screening Laboratory Testing ServicesThis contract is for the provision of newborn screening laboratory testing services required by state mandates, encompassing first, second, and repeat screenings for metabolic, genetic, and congenital disorders using specialized diagnostic assays. The work involves highly precise laboratory procedures to detect rare but serious conditions in newborns, ensuring early intervention and improved health outcomes. All testing must meet stringent quality and regulatory standards to guarantee accuracy and timeliness, with results delivered promptly to healthcare providers. The contract is a subcontract advertised by the Navajo Area Indian Health Service under the U.S. Department of Health and Human Services, with performance expected to occur in the 86503 zip code area. It falls under NAICS code 621511 for medical and diagnostic laboratories and has a response deadline of August 14, 2026. The solicitation does not specify a set-aside type or point of contact, and the location details for the agency’s office are incomplete, but the place of performance is clearly defined to ensure services are delivered within the designated service region.

Navajo Area Indian Health Svc

POSTED

DEADLINE

First Responder and Treatment Provider CoordinationThe contract targets the coordination between first responders and treatment providers to enable immediate warm handoffs of individuals following an opioid overdose, ensuring seamless transitions from emergency response to addiction treatment services. The initiative is managed by the Bureau of Substance Addiction Services in Massachusetts, with performance centered in Boston, ZIP 02108, and it is structured as a subcontract under NAICS code 621511, which pertains to outpatient mental health and substance abuse facilities. The solicitation was posted on July 29, 2026, with a response deadline of August 7, 2026, indicating a narrow window for interested parties to submit proposals aimed at improving system-level response to overdose events. The goal is to create a reliable, real-time link between emergency personnel and treatment centers so that individuals who survive an overdose are connected to care without delay, reducing the risk of recurrence and improving long-term recovery outcomes. The contract emphasizes operational efficiency, data sharing protocols, and collaborative workflows between law enforcement, EMS, and behavioral health providers. While no set-aside type or point of contact is specified, the emphasis on location and the nature of the services suggest a focus on urban, high-demand areas within Boston where overdose incidents are frequent and access to timely intervention is critical.

BSAS0 - Bureau of Substance Addiction Services

POSTED

DEADLINE

Field Administration of Buprenorphine (MOUD Delivery)The contract seeks to deliver buprenorphine in emergency field settings such as ambulances and mobile treatment units to initiate medication for opioid use disorder immediately after an overdose. The goal is to provide rapid, on-site intervention to stabilize individuals and begin evidence-based treatment without delay, bridging the gap between emergency response and long-term care. This initiative targets populations in acute crisis and aims to increase access to Medication for Opioid Use Disorder in environments where traditional clinical services are not immediately available. The solicitation is issued under NAICS code 621511, which pertains to outpatient care centers for substance use disorders, and is structured as a subcontract under the Bureau of Substance Addiction Services in Massachusetts. Responses are due by August 7, 2026, with performance centered in Boston, specifically at the 02108 zip code area. The program emphasizes operational readiness, cold-chain logistics for medication stability, and protocols for first responders and mobile clinicians to safely and effectively administer buprenorphine in non-traditional settings, aligning with public health strategies to reduce overdose fatalities and connect individuals to sustained recovery services.

BSAS0 - Bureau of Substance Addiction Services

POSTED

DEADLINE

Case Management for Opioid Use Disorder (OUD)This contract seeks to deliver comprehensive case management services for individuals with opioid use disorder, encompassing initial assessments, individualized care planning, linkage to medication-assisted treatment for opioid use disorder, and coordinated care across medical, behavioral health, and social service systems. The goal is to ensure holistic, person-centered support that addresses the complex needs of affected individuals through integrated service delivery. Services must be delivered in Boston, Massachusetts, with a performance location specified as 02108, and the work is structured as a subcontract under the Bureau of Substance Addiction Services of Massachusetts. The solicitation was posted on July 29, 2026, and proposals are due by August 7, 2026. The NAICS code 621511 identifies this as a substance abuse treatment facility service, indicating a focus on outpatient and residential behavioral health interventions. The contract does not specify a set-aside classification or organization type, leaving participation open to eligible subcontractors capable of meeting the required service standards. All service delivery must align with state standards for OUD care and involve active coordination with healthcare providers, social workers, and community resources to sustain recovery outcomes.

BSAS0 - Bureau of Substance Addiction Services

POSTED

DEADLINE

Peer Recovery Support ServicesThe contract seeks to deploy certified peer recovery coaches to deliver one-on-one mentorship and support services to individuals recovering from opioid use disorder, with the goal of improving recovery outcomes through lived experience-based guidance. Services are to be provided in Boston, Massachusetts, under the authority of the Bureau of Substance Addiction Services, and the work is structured as a subcontract. All peer recovery coaches must be certified and trained to offer culturally competent, trauma-informed support aligned with evidence-based practices in addiction recovery. The opportunity is open for responses until August 7, 2026, and is classified under NAICS code 621511, indicating it pertains to outpatient mental health and substance abuse centers. The place of performance is specified as Floor Boston, with no additional office address or point of contact details provided in the posting.

BSAS0 - Bureau of Substance Addiction Services

POSTED

DEADLINE

Post-Overdose Outreach and Engagement ServicesThe contract seeks to deliver post-overdose outreach and engagement services to individuals following a non-fatal opioid overdose, with the goal of providing immediate support, education on risk reduction, and direct linkage to recovery and treatment services. The effort is designed to intervene at a critical moment to prevent future overdoses and promote long-term recovery by connecting individuals to appropriate care resources. Services must be conducted in a compassionate, trauma-informed manner and tailored to meet the needs of individuals in Boston, with performance centered at the designated location in the 02108 zip code. This is a subcontract under the Bureau of Substance Addiction Services in Massachusetts, aligning with broader public health initiatives to combat the opioid crisis through proactive, community-based intervention. The solicitation, posted on July 29, 2026, requires proposals to be submitted by August 7, 2026, and is classified under NAICS code 621511 for outpatient mental health and substance abuse services. Although no set-aside type is specified, the agency is seeking qualified entities capable of delivering timely, evidence-based outreach with demonstrated experience in addiction services and community engagement. All work must be performed in Boston, and responders are expected to have the capacity to coordinate with local health systems, first responders, and recovery networks to ensure seamless service delivery. The contract emphasizes rapid follow-up, cultural competency, and measurable outcomes to track engagement success and reduce repeat overdose events.

BSAS0 - Bureau of Substance Addiction Services

POSTED

DEADLINE

CLIA-Compliant Laboratory Support Services

DAS Procurement

POSTED

DEADLINE

Biochemical and Metabolic Testing ServicesThe contract seeks specialized biochemical and metabolic testing services to support the diagnosis of rare metabolic and mitochondrial disorders in undiagnosed patients, with a focus on amino acid profiling, organic acid analysis, and enzyme assays. These analyses are critical for identifying underlying biochemical abnormalities that may not be detectable through standard diagnostic methods, enabling more accurate clinical decision-making and personalized patient care. The work is to be performed at the designated location in Bethesda, Maryland, with a performance timeframe aligned with the federal funding cycle and regulatory requirements for clinical diagnostic laboratories. This subcontract is issued under the National Institutes of Health, Office of Laboratory Animal Welfare, and falls under the NAICS code 621511 for medical and diagnostic laboratories. The opportunity was posted on July 28, 2026, with a response deadline of August 7, 2026, and is part of a broader effort by the Department of Health and Human Services to expand diagnostic capabilities for complex genetic and metabolic conditions. While no specific set-aside provisions are indicated, the subcontractor must possess the technical expertise, validated methodologies, and regulatory compliance necessary to deliver high-confidence results in a clinical research environment.

National Institutes Of Health Olao

POSTED

DEADLINE

Clinical Genetic Testing and Interpretation ServicesThe contract calls for the provision of CLIA-certified genetic testing services, specifically focusing on whole exome sequencing and the generation of interpretive reports that connect identified genetic variants to clinical phenotypes for the diagnosis of rare diseases. The work must be performed in compliance with all applicable clinical laboratory standards and requires the technical expertise to analyze complex genomic data and deliver actionable, clinically relevant interpretations. The services are intended to support diagnostic efforts within a research or clinical setting, with deliverables centered on accurate, evidence-based reporting that aids in patient care and rare disease identification. This is a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with performance required at the Bethesda location with a zip code of 20892. The solicitation was posted on July 28, 2026, and responses are due by August 7, 2026, with a NAICS code of 621511 indicating it falls under medical and diagnostic laboratories. There is no set-aside designation noted, and the contract does not include specific point of contact details, but interested parties must adhere to the submission deadline and ensure full compliance with CLIA and clinical reporting standards to be considered for award.

National Institutes Of Health Olao

POSTED

DEADLINE

Clinical Laboratory Testing Services (CPT-Based)The contract obligates the provider to deliver clinical laboratory testing services in full compliance with CLIA and CAP standards, specifically for specimens sourced from military personnel, with a strict 48-hour turnaround requirement for result delivery. All testing must be billed using CPT-based coding and performed to ensure accuracy, reliability, and regulatory adherence throughout the testing lifecycle. The work is to be conducted at the designated place of performance in Flowood, Mississippi, with the contract operating under a subcontract structure and governed by the NAICS code 621511, which classifies it as a clinical laboratory service. The solicitation was posted on July 28, 2026, and responses are due by August 26, 2026, with the awarding entity being the Department of Defense through its W7NH Uspfo Activity Msang 172 office.

W7NH Uspfo Activity Msang 172

POSTED

DEADLINE

HLA Typing and Crossmatch Testing ServicesThe contract requires the performance of high-resolution HLA typing and crossmatch testing to support organ transplant donor-recipient compatibility, utilizing both molecular and serological methodologies to ensure accurate and reliable identification of human leukocyte antigens. These services are critical for minimizing transplant rejection and improving long-term graft survival, with testing procedures adhering to established clinical and laboratory standards for transplant immunology. The work must be conducted with precision and timeliness to meet the urgent timelines inherent in organ transplantation processes. The contract is classified as a subcontract under the NAICS code 621511, issued by the Department of Veterans Affairs through the 249-NETWORK Contract Office 9, with performance expected to take place in the zip code area 37212. All proposals must be submitted by the deadline of August 24, 2026, and while no set-aside provisions are specified, the solicitation is open to qualified subcontractors capable of delivering accredited, high-throughput HLA testing services. The agency has not designated a point of contact, and further details are accessible through the provided SAM.gov link.

249-NETWORK Contract Office 9 (36C249)

POSTED

DEADLINE

Blood Testing and Laboratory AnalysisThis contract encompasses comprehensive blood testing and laboratory analysis services required for infectious disease screening, including testing for HIV, HBV, HCV, syphilis, and West Nile virus, as well as blood typing, antibody screening, and quality control of collected blood units. The work is performed under a subcontract arrangement managed by the Department of Veterans Affairs through its 244-NETWORK Contract Office 4, with performance location specified in Pittsburgh. The North American Industry Classification System code 621511 indicates the service falls under medical and diagnostic laboratories, emphasizing precision and compliance with clinical laboratory standards. All testing procedures must meet stringent quality assurance protocols to ensure the safety and suitability of blood products for transfusion purposes.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

172 AW Lab Services IDIQ

Solicitation # W50S7H26RA001

The U.S. Air Force’s 172d Airlift Wing is soliciting proposals for a five-year, firm-fixed-price Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract under solicitation number W50S7H-26-R-A001 to obtain comprehensive medical laboratory testing services. This is a 100% small business set-aside with a size standard of $41.5 million, targeted at NAICS code 621511 for medical laboratories. Proposals must be submitted electronically by August 26, 2026, and must include a detailed price schedule covering all services listed in the Performance Work Statement, formatted in MS Excel or PDF. Pricing must reflect unit costs for all five years of the ordering period, and any transaction fees associated with Government Purchase Card (GPC) use must be explicitly stated—otherwise, no surcharges will be assumed. The contract will be awarded using the Best Value Trade-Off process under FAR 13.5 and Part 12, prioritizing technical capability and past performance over price, though price remains a critical component evaluated for reasonableness and balance. Technical proposals must demonstrate compliance with CLIA/CAP certifications, a clear operational plan for sample collection and turnaround times within a Sunday-through-Saturday 0730–1600 window, and confirmation that all laboratory facilities are within 30 minutes’ drive of the 172d Airlift Wing and strictly within the Jackson MSA. Orders under the resulting IDIQ will be placed using either the GPC for transactions up to $25,000 or DD Form 1155 Delivery Orders for amounts above that threshold, with electronic funds transfer processed through WAWF. GPC usage is the primary execution method for low-value orders to accelerate payment cycles, and only authorized cardholders designated by the 172d Medical Group may issue such orders. Contractors must accept both GPC and Delivery Order payment mechanisms, and all invoicing must comply with WAWF requirements, including the use of specified DoDAACs for payment routing. The evaluation process will rate technical capability as the most critical factor, with subfactors for licensing, operational capability, and geographic compliance acting as gatekeepers—failure in any one will render a proposal unacceptable. Past performance will be assessed for relevance and recency within the past three years, and price will be analyzed for total evaluated cost based on estimated volumes

W7NH Uspfo Activity Msang 172

POSTED

DEADLINE

Q515--MO - HLA Testing - 626 Tennessee Valley Healthcare System HLA Transplant Testing Services POP: 10/1/2026-9/30/2032

Solicitation # 36C24926R0076

The Department of Veterans Affairs, through Network Contracting Office 9, has issued a solicitation for HLA Transplant Testing Services to support the Tennessee Valley Healthcare System in Nashville, Tennessee. The contract has a performance period extending from October 1, 2026, through September 30, 2032, and is identified by solicitation number 36C24926R0076 under NAICS code 621511 and Product Service Code Q515. Proposals are due by August 24, 2026, with submissions to be directed to the contracting office located in Murfreesboro, Tennessee. The primary point of contact is Contract Specialist Rebecca Espinoza, reachable via email at rebecca.espinoza@va.gov. The place of performance is the Tennessee Valley Healthcare System’s facility at 1310 24th Avenue South, Nashville, TN 37212. The solicitation is for specialized clinical laboratory services critical to organ transplant compatibility assessments, though detailed specifications, deliverables, evaluation factors, pricing terms, and contractual clauses have not yet been released in the available documentation. Information regarding inspection criteria, packaging and labeling requirements, quality standards such as CLIA or CAP, invoicing procedures, accounting data, key personnel qualifications, and special requirements including security clearances or organizational conflict of interest provisions remain unspecified and are expected to be detailed in the full solicitation package when published. No set-aside status has been designated, and no attachment lists, contract clauses, or evaluation factors are currently accessible. All cost information, line-item details, and submission formatting instructions are pending release. Offerors must await the official solicitation for comprehensive guidance on compliance, technical requirements, and award methodology.

249-NETWORK Contract Office 9 (36C249)

POSTED

DEADLINE

Clinical Laboratory Testing and Specialized Biochemical AnalysisServices for the NHGRI Undiagnosed Diseases Program (UDP) through Baylor Genetics Laboratory

Solicitation # 75N98026Q00900

The contract entails the provision of CLIA-certified clinical laboratory testing and specialized biochemical analysis services for the National Human Genome Research Institute’s Undiagnosed Diseases Program, under NIH protocol 15-HG-0130, through Baylor Genetics Laboratory. The work supports the evaluation of patients with complex, rare, and previously undiagnosed multisystem disorders, focusing on genetic, metabolic, and mitochondrial conditions. Services include advanced testing such as mitochondrial DNA copy number quantification, assessment of mitochondrial deletions, metabolomic profiling, biochemical pathway analysis, and testing of tissues including muscle, liver, fibroblasts, blood, and urine, along with follow-up family studies when authorized. All testing must adhere to federal and state regulations, using validated methodologies and maintained quality assurance systems to ensure accuracy and compliance. The contractor is required to deliver comprehensive laboratory reports with clinical interpretations and limitations within established turnaround times, using secure, privacy-compliant transmission methods. Immediate notification of critical or clinically significant findings is mandatory to support urgent patient care. Technical consultation services are essential, including guidance on test selection, specimen handling, result interpretation, and recommendations for additional testing. The contractor must also actively participate in scientific and clinical discussions as requested by NIH. The solicitation, numbered 75N98026Q00900, is issued by the National Institutes of Health within the Department of Health and Human Services, with responses due by August 7, 2026, and performance primarily based in Bethesda, Maryland.

National Institutes Of Health Olao

POSTED

DEADLINE